Holen Sie sich die Stockscreener-App
28.50
3.45%
0.95
Schlusskurs vom Vortag:
$27.55
Offen:
$27.82
24-Stunden-Volumen:
268.69K
Relative Volume:
0.74
Marktkapitalisierung:
$1.31B
Einnahmen:
$722.68M
Nettoeinkommen (Verlust:
$134.71M
KGV:
10.67
EPS:
2.67
Netto-Cashflow:
$109.94M
1W Leistung:
-2.60%
1M Leistung:
-1.42%
6M Leistung:
-6.50%
1J Leistung:
-10.21%
1-Tages-Spanne:
$27.76
$29.00
1-Wochen-Bereich:
$27.24
$29.20
52-Wochen-Spanne:
$20.39
$32.69
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Firmenname
Amphastar Pharmaceuticals Inc
Sektor
Telefon
909-980-9484
Adresse
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
28.50 | 1.27B | 722.68M | 134.71M | 109.94M | 2.67 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.46 | 58.03B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
126.65 | 55.37B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.20 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.98 | 39.50B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.66 | 20.50B | 3.13B | 1.27B | 1.12B | 26.39 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-08-12 | Hochstufung | Needham | Hold → Buy |
| 2025-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2023-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2023-07-25 | Fortgesetzt | Jefferies | Buy |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-07-29 | Eingeleitet | CapitalOne | Overweight |
| 2022-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Eingeleitet | Northland Capital | Outperform |
| 2019-03-13 | Herabstufung | Needham | Buy → Hold |
| 2019-03-13 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Bestätigt | Needham | Buy |
| 2018-03-13 | Bestätigt | Needham | Buy |
| 2017-12-01 | Bestätigt | Needham | Buy |
| 2017-11-09 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Bestätigt | Needham | Buy |
| 2017-03-14 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Bestätigt | Needham | Buy |
| 2016-05-10 | Bestätigt | Needham | Buy |
| 2016-02-19 | Eingeleitet | Wells Fargo | Outperform |
| 2015-06-19 | Bestätigt | Needham | Buy |
| 2015-06-03 | Eingeleitet | Raymond James | Strong Buy |
| 2014-07-21 | Eingeleitet | Needham | Buy |
Alle ansehen
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Mixed Recent Share Performance - Yahoo Finance
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know - Finviz
Is Amphastar Pharmaceuticals Inc. a top pick in the sector2025 Key Highlights & Free Fast Gain Swing Trade Alerts - mfd.ru
Do Options Traders Know Something About Amphastar Pharmaceuticals Stock We Don't? - Nasdaq
How (AMPH) Movements Inform Risk Allocation Models - Stock Traders Daily
Market Review: Can Amphastar Pharmaceuticals Inc maintain its current growth rateJuly 2025 Intraday Action & Community Shared Stock Ideas - baoquankhu1.vn
Why Amphastar Pharmaceuticals Inc. stock is a must watch in 2025 - mfd.ru
Amphastar Pharmaceuticals, Inc. $AMPH Shares Bought by New York State Common Retirement Fund - MarketBeat
Market Catalysts: Can Amphastar Pharmaceuticals Inc maintain its current growth rateMarket Growth Summary & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Is Amphastar Pharmaceuticals (NASDAQ:AMPH) A Risky Investment? - 富途牛牛
Is Amphastar (AMPH) Turning Margin Compression Into a Test of Its Operational Discipline? - Sahm
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Cross Above 50-Day Moving AverageHere's Why - MarketBeat
Whale Trades: Is Amphastar Pharmaceuticals Inc backed by strong institutional buyingJuly 2025 Drop Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
SummerHaven Investment Management LLC Takes $1.02 Million Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a Potential 18.69% Upside for Investors - DirectorsTalk Interviews
Can Amphastar Pharmaceuticals Inc. maintain its current growth rateJuly 2025 Macro Moves & Weekly High Potential Stock Alerts - mfd.ru
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
How Amphastar Pharmaceuticals Inc. (AMPH) Affects Rotational Strategy Timing - Stock Traders Daily
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 21% Potential Upside for Investors - DirectorsTalk Interviews
Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock? - sharewise.com
Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving - Finviz
A Look At Amphastar Pharmaceuticals (AMPH) Valuation After The AMP-110 License Agreement With Nanjing Hanxin - Yahoo Finance
Amphastar Pharmaceuticals Touts Shift to Proprietary Drugs, Teases AMP-007 Launch and Baqsimi Growth - MarketBeat
2 Reasons to Avoid AMPH and 1 Stock to Buy Instead - Yahoo Finance
Aug Opening: Will Amphastar Pharmaceuticals Inc stock recover faster than peers2025 Price Targets & Smart Investment Allocation Tips - Bộ Nội Vụ
Earnings Recap: Will Amphastar Pharmaceuticals Inc stock pay special dividends2025 Big Picture & Capital Protection Trade Alerts - Bộ Nội Vụ
Amphastar licenses synthetic ACTH analog for inflammatory conditions By Investing.com - Investing.com Nigeria
Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook With A 7.39% Upside Potential - DirectorsTalk Interviews
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today - Finviz
Amphastar Licenses ACTH Analog AMP-110 for North America - TipRanks
Amphastar Pharmaceuticals Signs Multiple Material Agreements - TradingView
Amphastar, Hanxin Enter Exclusive License Agreement for AMP-110 - Contract Pharma
Amphastar licenses synthetic ACTH analog for inflammatory conditions - Investing.com
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound - ACCESS Newswire
New synthetic hormone treatment targets autoimmune and inflammatory conditions - Stock Titan
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Could Be Riskier Than It Looks - 富途牛牛
The Bull Case For Amphastar Pharmaceuticals (AMPH) Could Change Following New BofA Coverage And JPM Spotlight - Yahoo Finance
(AMPH) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Is Amphastar Pharmaceuticals Inc. stock a smart buy before Fed meetingExit Point & Daily Profit Focused Screening - Улправда
Is Amphastar Pharmaceuticals (AMPH) Attractively Priced After Recent Share Price Weakness? - Sahm
Amphastar Pharmaceuticals, Inc. $AMPH Stock Holdings Trimmed by CX Institutional - MarketBeat
Why Amphastar Pharmaceuticals Inc. stock remains undervaluedJuly 2025 PostEarnings & Expert-Curated Trade Recommendations - Улправда
Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Momentum - Sahm
Will Amphastar Pharmaceuticals Inc. stock benefit from AI adoption2025 Support & Resistance & Fast Entry High Yield Stock Tips - Улправда
Is Amphastar Pharmaceuticals Inc. stock affected by interest rate hikesWeekly Profit Report & High Return Trade Opportunity Guides - ulpravda.ru
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference - ACCESS Newswire
Amphastar Expands BAQSIMI® Distribution in Asia - MSN
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring an 18.69% Upside Potential - DirectorsTalk Interviews
Value Recap: Is Amphastar Pharmaceuticals Inc stock trading near support levels2025 Technical Patterns & Weekly Breakout Watchlists - moha.gov.vn
Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Amphastar Pharmaceuticals Inc-Aktie (AMPH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Zhou Rong | SENIOR EVP, PRODUCTION CENTER |
Dec 17 '25 |
Sale |
26.20 |
9,787 |
256,379 |
138,043 |
| Petersen Floyd F. | Director |
Dec 12 '25 |
Sale |
25.92 |
2,426 |
62,888 |
71,368 |
| Petersen Floyd F. | Director |
Dec 11 '25 |
Sale |
25.69 |
1,737 |
44,620 |
73,794 |
1.19%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):